Ontology | Accession | Term | GO Evidence | Evidence Ontology (ECO) Code | Reference | Comments |
---|---|---|---|---|---|---|
Cellular Component | GO:0016020 | membrane |
Inferred from Sequence Model
Term mapped from: InterPro:TIGR00711
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
||
Biological Process | GO:0055085 | transmembrane transport |
Inferred from Sequence Model
Term mapped from: InterPro:PF07690
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
||
Molecular Function | GO:0022857 | transmembrane transporter activity |
Inferred from Sequence Model
Term mapped from: InterPro:PF07690
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
|
Analysis | Accession | Description | Interpro Accession | Interpro Description | Amino Acid Start | Amino Acid Stop | E-value |
---|---|---|---|---|---|---|---|
Gene3D | G3DSA:1.20.1250.20 | MFS general substrate transporter like domains | IPR036259 | MFS transporter superfamily | 10 | 429 | 4.3E-50 |
CDD | cd17503 | MFS_LmrB_MDR_like | - | - | 19 | 487 | 8.93721E-94 |
Pfam | PF07690 | Major Facilitator Superfamily | IPR011701 | Major facilitator superfamily | 19 | 412 | 1.0E-43 |
SUPERFAMILY | SSF103473 | MFS general substrate transporter | IPR036259 | MFS transporter superfamily | 7 | 500 | 1.44E-60 |
NCBIfam | TIGR00711 | JCVI: DHA2 family efflux MFS transporter permease subunit | IPR004638 | Drug resistance transporter EmrB-like | 19 | 494 | 1.2E-107 |
PANTHER | PTHR23501 | MAJOR FACILITATOR SUPERFAMILY | - | - | 7 | 498 | 4.1E-81 |